pI: 4.8667 |
Length (AA): 433 |
MW (Da): 48278 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
NA% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128779)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G25900 | homocysteine S-methyltransferase 1 |
Arabidopsis thaliana | AT3G22740 | homocysteine S-methyltransferase 3 |
Arabidopsis thaliana | AT3G63250 | homocysteine S-methyltransferase 2 |
Brugia malayi | Bm1_40665 | probable homocysteine S-methyltransferase |
Candida albicans | CaO19.386 | S-adenosylmethionine:homocysteine S-methyltransferase |
Candida albicans | CaO19.8016 | S-adenosylmethionine:homocysteine S-methyltransferase |
Caenorhabditis elegans | CELE_T13G4.4 | Protein T13G4.4 |
Drosophila melanogaster | Dmel_CG10623 | CG10623 gene product from transcript CG10623-RC |
Drosophila melanogaster | Dmel_CG10621 | CG10621 gene product from transcript CG10621-RA |
Escherichia coli | b0261 | CP4-6 prophage |
Leishmania braziliensis | LbrM.35.6610 | homocysteine S-methyltransferase, putative |
Leishmania donovani | LdBPK_366570.1 | homocysteine S-methyltransferase, putative |
Leishmania major | LmjF.36.6310 | homocysteine S-methyltransferase, putative |
Leishmania mexicana | LmxM.36.6310 | homocysteine S-methyltransferase, putative |
Loa Loa (eye worm) | LOAG_05038 | hypothetical protein |
Mycobacterium leprae | ML1478 | PROBABLE HOMOCYSTEINE S-METHYLTRANSFERASE MMUM (S-METHYLMETHIONINE:HOMOCYSTEINE METHYLTRANSFERASE) (CYSTEINE METHYLTRANSFERASE) |
Mycobacterium tuberculosis | Rv2458 | Probable homocysteine S-methyltransferase MmuM (S-methylmethionine:homocysteine methyltransferase) (cysteine methyltransferase) |
Neospora caninum | NCLIV_028500 | GJ17676, related |
Oryza sativa | 4348656 | Os10g0422200 |
Oryza sativa | 4352747 | Os12g0607000 |
Oryza sativa | 4332095 | Os03g0221200 |
Oryza sativa | 4324713 | Os01g0772900 |
Onchocerca volvulus | OVOC5306 |
|
Saccharomyces cerevisiae | YPL273W | Sam4p |
Saccharomyces cerevisiae | YLL062C | Mht1p |
Schistosoma japonicum | Sjp_0063340 | ko:K00547 homocysteine S-methyltransferase [EC2.1.1.10], putative |
Schistosoma japonicum | Sjp_0063350 | Transmembrane protein 185B, putative |
Schistosoma mansoni | Smp_147610 | hypothetical protein |
Schmidtea mediterranea | mk4.001783.04 | |
Trypanosoma brucei gambiense | Tbg972.1.590 | homocysteine S-methyltransferase, putative |
Trypanosoma brucei | Tb927.1.1270 | homocysteine S-methyltransferase, putative |
Trypanosoma congolense | TcIL3000_0_17710 | homocysteine S-methyltransferase, putative |
Trypanosoma congolense | TcIL3000_1_760 | homocysteine S-methyltransferase, putative |
Trypanosoma cruzi | TcCLB.506479.120 | cytidine triphosphate synthase, putative |
Trypanosoma cruzi | TcCLB.508993.20 | homocysteine S-methyltransferase, putative |
Toxoplasma gondii | TGME49_257750 | homocysteine s-methyltransferase domain-containing protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.1.1270 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.1.1270 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.1.1270 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.1.1270 this record | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0261 | Escherichia coli | non-essential | goodall |
TGME49_257750 | Toxoplasma gondii | Probably non-essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.